IBDEI0IW ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25426,1,5,0)
 ;;=5^TINEA PEDIS
 ;;^UTILITY(U,$J,358.3,25426,2)
 ;;=^33168
 ;;^UTILITY(U,$J,358.3,25427,0)
 ;;=525.9^^162^1532^5
 ;;^UTILITY(U,$J,358.3,25427,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25427,1,2,0)
 ;;=2^525.9
 ;;^UTILITY(U,$J,358.3,25427,1,5,0)
 ;;=5^TOOTHACHE
 ;;^UTILITY(U,$J,358.3,25427,2)
 ;;=^123871
 ;;^UTILITY(U,$J,358.3,25428,0)
 ;;=465.9^^162^1532^12
 ;;^UTILITY(U,$J,358.3,25428,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25428,1,2,0)
 ;;=2^465.9
 ;;^UTILITY(U,$J,358.3,25428,1,5,0)
 ;;=5^URI,ACUTE
 ;;^UTILITY(U,$J,358.3,25428,2)
 ;;=^269878
 ;;^UTILITY(U,$J,358.3,25429,0)
 ;;=599.0^^162^1532^16
 ;;^UTILITY(U,$J,358.3,25429,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25429,1,2,0)
 ;;=2^599.0
 ;;^UTILITY(U,$J,358.3,25429,1,5,0)
 ;;=5^UTI
 ;;^UTILITY(U,$J,358.3,25429,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,25430,0)
 ;;=597.80^^162^1532^11
 ;;^UTILITY(U,$J,358.3,25430,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25430,1,2,0)
 ;;=2^597.80
 ;;^UTILITY(U,$J,358.3,25430,1,5,0)
 ;;=5^URETHRITIS NOS
 ;;^UTILITY(U,$J,358.3,25430,2)
 ;;=^124214
 ;;^UTILITY(U,$J,358.3,25431,0)
 ;;=788.41^^162^1532^13
 ;;^UTILITY(U,$J,358.3,25431,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25431,1,2,0)
 ;;=2^788.41
 ;;^UTILITY(U,$J,358.3,25431,1,5,0)
 ;;=5^URINARY FREQUENCY
 ;;^UTILITY(U,$J,358.3,25431,2)
 ;;=^124396
 ;;^UTILITY(U,$J,358.3,25432,0)
 ;;=788.30^^162^1532^14
 ;;^UTILITY(U,$J,358.3,25432,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25432,1,2,0)
 ;;=2^788.30
 ;;^UTILITY(U,$J,358.3,25432,1,5,0)
 ;;=5^URINARY INCONTINENCE, UNSPEC
 ;;^UTILITY(U,$J,358.3,25432,2)
 ;;=^124400
 ;;^UTILITY(U,$J,358.3,25433,0)
 ;;=788.20^^162^1532^15
 ;;^UTILITY(U,$J,358.3,25433,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25433,1,2,0)
 ;;=2^788.20
 ;;^UTILITY(U,$J,358.3,25433,1,5,0)
 ;;=5^URINARY RETENTION
 ;;^UTILITY(U,$J,358.3,25433,2)
 ;;=^295812
 ;;^UTILITY(U,$J,358.3,25434,0)
 ;;=532.90^^162^1532^6
 ;;^UTILITY(U,$J,358.3,25434,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25434,1,2,0)
 ;;=2^532.90
 ;;^UTILITY(U,$J,358.3,25434,1,5,0)
 ;;=5^ULCER,DUODENAL
 ;;^UTILITY(U,$J,358.3,25434,2)
 ;;=^37311
 ;;^UTILITY(U,$J,358.3,25435,0)
 ;;=531.90^^162^1532^7
 ;;^UTILITY(U,$J,358.3,25435,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25435,1,2,0)
 ;;=2^531.90
 ;;^UTILITY(U,$J,358.3,25435,1,5,0)
 ;;=5^ULCER,GASTRIC
 ;;^UTILITY(U,$J,358.3,25435,2)
 ;;=^51128
 ;;^UTILITY(U,$J,358.3,25436,0)
 ;;=533.90^^162^1532^9
 ;;^UTILITY(U,$J,358.3,25436,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25436,1,2,0)
 ;;=2^533.90
 ;;^UTILITY(U,$J,358.3,25436,1,5,0)
 ;;=5^ULCER,PEPTIC
 ;;^UTILITY(U,$J,358.3,25436,2)
 ;;=^93051
 ;;^UTILITY(U,$J,358.3,25437,0)
 ;;=707.10^^162^1532^8
 ;;^UTILITY(U,$J,358.3,25437,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25437,1,2,0)
 ;;=2^707.10
 ;;^UTILITY(U,$J,358.3,25437,1,5,0)
 ;;=5^ULCER,LOWER LIMB
 ;;^UTILITY(U,$J,358.3,25437,2)
 ;;=^322142
 ;;^UTILITY(U,$J,358.3,25438,0)
 ;;=707.9^^162^1532^10
 ;;^UTILITY(U,$J,358.3,25438,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25438,1,2,0)
 ;;=2^707.9
 ;;^UTILITY(U,$J,358.3,25438,1,5,0)
 ;;=5^ULCER,SKIN NOS
 ;;^UTILITY(U,$J,358.3,25438,2)
 ;;=^24439
 ;;^UTILITY(U,$J,358.3,25439,0)
 ;;=Q3014^^163^1533^1^^^^1
 ;;^UTILITY(U,$J,358.3,25439,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25439,1,2,0)
 ;;=2^Q3014
 ;;^UTILITY(U,$J,358.3,25439,1,3,0)
 ;;=3^Telehealth Fac Fee-Pt Site
 ;;^UTILITY(U,$J,358.3,25440,0)
 ;;=Q3014^^164^1534^5^^^^1
 ;;^UTILITY(U,$J,358.3,25440,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25440,1,2,0)
 ;;=2^Q3014
 ;;^UTILITY(U,$J,358.3,25440,1,3,0)
 ;;=3^TELEHEALTH FACILITY FEE
 ;;^UTILITY(U,$J,358.3,25441,0)
 ;;=92227^^164^1534^3^^^^1
 ;;^UTILITY(U,$J,358.3,25441,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25441,1,2,0)
 ;;=2^92227
 ;;^UTILITY(U,$J,358.3,25441,1,3,0)
 ;;=3^REMOTE DX RETINAL IMAGING
 ;;^UTILITY(U,$J,358.3,25442,0)
 ;;=92228^^164^1534^4^^^^1
 ;;^UTILITY(U,$J,358.3,25442,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25442,1,2,0)
 ;;=2^92228
 ;;^UTILITY(U,$J,358.3,25442,1,3,0)
 ;;=3^REMOTE IMAGING-RETINAL MGMT
 ;;^UTILITY(U,$J,358.3,25443,0)
 ;;=92250^^164^1534^1^^^^1
 ;;^UTILITY(U,$J,358.3,25443,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25443,1,2,0)
 ;;=2^92250
 ;;^UTILITY(U,$J,358.3,25443,1,3,0)
 ;;=3^FUNDUS PHOTO W/ INTERP & RPT
 ;;^UTILITY(U,$J,358.3,25444,0)
 ;;=T1014^^164^1534^6^^^^1
 ;;^UTILITY(U,$J,358.3,25444,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25444,1,2,0)
 ;;=2^T1014
 ;;^UTILITY(U,$J,358.3,25444,1,3,0)
 ;;=3^TELEHEALTH TRANSMIT, PER MIN
 ;;^UTILITY(U,$J,358.3,25445,0)
 ;;=3072F^^164^1534^2^^^^1
 ;;^UTILITY(U,$J,358.3,25445,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25445,1,2,0)
 ;;=2^3072F
 ;;^UTILITY(U,$J,358.3,25445,1,3,0)
 ;;=3^LOW RISK FOR RETINOPATHY
 ;;^UTILITY(U,$J,358.3,25446,0)
 ;;=373.32^^165^1535^48
 ;;^UTILITY(U,$J,358.3,25446,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25446,1,3,0)
 ;;=3^Eyelid,Dermatitis,Allergic
 ;;^UTILITY(U,$J,358.3,25446,1,4,0)
 ;;=4^373.32
 ;;^UTILITY(U,$J,358.3,25446,2)
 ;;=^269061
 ;;^UTILITY(U,$J,358.3,25447,0)
 ;;=373.00^^165^1535^4
 ;;^UTILITY(U,$J,358.3,25447,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25447,1,3,0)
 ;;=3^Blepharitis
 ;;^UTILITY(U,$J,358.3,25447,1,4,0)
 ;;=4^373.00
 ;;^UTILITY(U,$J,358.3,25447,2)
 ;;=Blepharitis^15271
 ;;^UTILITY(U,$J,358.3,25448,0)
 ;;=373.2^^165^1535^7
 ;;^UTILITY(U,$J,358.3,25448,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25448,1,3,0)
 ;;=3^Chalazion
 ;;^UTILITY(U,$J,358.3,25448,1,4,0)
 ;;=4^373.2
 ;;^UTILITY(U,$J,358.3,25448,2)
 ;;=^22156
 ;;^UTILITY(U,$J,358.3,25449,0)
 ;;=374.84^^165^1535^29
 ;;^UTILITY(U,$J,358.3,25449,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25449,1,3,0)
 ;;=3^Eyelid Cysts
 ;;^UTILITY(U,$J,358.3,25449,1,4,0)
 ;;=4^374.84
 ;;^UTILITY(U,$J,358.3,25449,2)
 ;;=^269119
 ;;^UTILITY(U,$J,358.3,25450,0)
 ;;=374.87^^165^1535^31
 ;;^UTILITY(U,$J,358.3,25450,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25450,1,3,0)
 ;;=3^Eyelid Dermatochalasis
 ;;^UTILITY(U,$J,358.3,25450,1,4,0)
 ;;=4^374.87
 ;;^UTILITY(U,$J,358.3,25450,2)
 ;;=^269123
 ;;^UTILITY(U,$J,358.3,25451,0)
 ;;=375.15^^165^1535^12
 ;;^UTILITY(U,$J,358.3,25451,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25451,1,3,0)
 ;;=3^Dry Eye Syndrome
 ;;^UTILITY(U,$J,358.3,25451,1,4,0)
 ;;=4^375.15
 ;;^UTILITY(U,$J,358.3,25451,2)
 ;;=Dry Eye Syndrome^37168
 ;;^UTILITY(U,$J,358.3,25452,0)
 ;;=374.01^^165^1535^20
 ;;^UTILITY(U,$J,358.3,25452,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25452,1,3,0)
 ;;=3^Entropion, Senile
 ;;^UTILITY(U,$J,358.3,25452,1,4,0)
 ;;=4^374.01
 ;;^UTILITY(U,$J,358.3,25452,2)
 ;;=Entropion, Senile^269074
 ;;^UTILITY(U,$J,358.3,25453,0)
 ;;=375.20^^165^1535^68
 ;;^UTILITY(U,$J,358.3,25453,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25453,1,3,0)
 ;;=3^Lacrimal,Epiphora
 ;;^UTILITY(U,$J,358.3,25453,1,4,0)
 ;;=4^375.20
 ;;^UTILITY(U,$J,358.3,25453,2)
 ;;=Epiphora^269136
 ;;^UTILITY(U,$J,358.3,25454,0)
 ;;=373.11^^165^1535^63
 ;;^UTILITY(U,$J,358.3,25454,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25454,1,3,0)
 ;;=3^Hordeolum Externum
 ;;^UTILITY(U,$J,358.3,25454,1,4,0)
 ;;=4^373.11
 ;;^UTILITY(U,$J,358.3,25454,2)
 ;;=^58510
 ;;^UTILITY(U,$J,358.3,25455,0)
 ;;=373.12^^165^1535^64
 ;;^UTILITY(U,$J,358.3,25455,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25455,1,3,0)
 ;;=3^Hordeolum Internum
 ;;^UTILITY(U,$J,358.3,25455,1,4,0)
 ;;=4^373.12
 ;;^UTILITY(U,$J,358.3,25455,2)
 ;;=^58512
 ;;^UTILITY(U,$J,358.3,25456,0)
 ;;=216.1^^165^1535^54
 ;;^UTILITY(U,$J,358.3,25456,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25456,1,3,0)
 ;;=3^Eyelid/Canthus,Benign Neopl
 ;;^UTILITY(U,$J,358.3,25456,1,4,0)
 ;;=4^216.1
 ;;^UTILITY(U,$J,358.3,25456,2)
 ;;=Neoplasm, Benign of Lid^267630
 ;;^UTILITY(U,$J,358.3,25457,0)
 ;;=374.30^^165^1535^43
 ;;^UTILITY(U,$J,358.3,25457,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25457,1,3,0)
 ;;=3^Eyelid Ptosis,Unspec
 ;;^UTILITY(U,$J,358.3,25457,1,4,0)
 ;;=4^374.30
 ;;^UTILITY(U,$J,358.3,25457,2)
 ;;=^15283
 ;;^UTILITY(U,$J,358.3,25458,0)
 ;;=375.30^^165^1535^9
 ;;^UTILITY(U,$J,358.3,25458,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25458,1,3,0)
 ;;=3^Dacryocystitis
 ;;^UTILITY(U,$J,358.3,25458,1,4,0)
 ;;=4^375.30
 ;;^UTILITY(U,$J,358.3,25458,2)
 ;;=Dacrocystitis^30880
 ;;^UTILITY(U,$J,358.3,25459,0)
 ;;=921.1^^165^1535^28
 ;;^UTILITY(U,$J,358.3,25459,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25459,1,3,0)
 ;;=3^Eyelid Contusion
 ;;^UTILITY(U,$J,358.3,25459,1,4,0)
 ;;=4^921.1
 ;;^UTILITY(U,$J,358.3,25459,2)
 ;;=^275367
 ;;^UTILITY(U,$J,358.3,25460,0)
 ;;=374.51^^165^1535^46
 ;;^UTILITY(U,$J,358.3,25460,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25460,1,3,0)
 ;;=3^Eyelid Xanthelasma
 ;;^UTILITY(U,$J,358.3,25460,1,4,0)
 ;;=4^374.51
 ;;^UTILITY(U,$J,358.3,25460,2)
 ;;=^269107
 ;;^UTILITY(U,$J,358.3,25461,0)
 ;;=374.11^^165^1535^15
 ;;^UTILITY(U,$J,358.3,25461,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25461,1,3,0)
 ;;=3^Ectropion, Senile
 ;;^UTILITY(U,$J,358.3,25461,1,4,0)
 ;;=4^374.11
 ;;^UTILITY(U,$J,358.3,25461,2)
 ;;=Ectropion, Senile^269083
 ;;^UTILITY(U,$J,358.3,25462,0)
 ;;=333.81^^165^1535^6
 ;;^UTILITY(U,$J,358.3,25462,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25462,1,3,0)
 ;;=3^Blepharospasm
 ;;^UTILITY(U,$J,358.3,25462,1,4,0)
 ;;=4^333.81
 ;;^UTILITY(U,$J,358.3,25462,2)
 ;;=Blepharospasm^15293
 ;;^UTILITY(U,$J,358.3,25463,0)
 ;;=351.8^^165^1535^62
 ;;^UTILITY(U,$J,358.3,25463,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25463,1,3,0)
 ;;=3^Hemifacial Spasm
 ;;^UTILITY(U,$J,358.3,25463,1,4,0)
 ;;=4^351.8
 ;;^UTILITY(U,$J,358.3,25463,2)
 ;;=Hemifacial Spasm^87589
 ;;^UTILITY(U,$J,358.3,25464,0)
 ;;=374.10^^165^1535^17
 ;;^UTILITY(U,$J,358.3,25464,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25464,1,3,0)
 ;;=3^Ectropion, Unspecified
 ;;^UTILITY(U,$J,358.3,25464,1,4,0)
 ;;=4^374.10
 ;;^UTILITY(U,$J,358.3,25464,2)
 ;;=Ectropion, Unspecified^38326
